Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-15-001276
Filing Date
2015-11-23
Accepted
2015-11-23 16:24:01
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mdst_10q.htm 10-Q 381029
2 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z1.htm EX-31.1 5842
3 OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT mdst_ex31z2.htm EX-31.2 5833
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 mdst_ex32z1.htm EX-32.1 3165
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 mdst_ex32z2.htm EX-32.2 3205
  Complete submission text file 0001553350-15-001276.txt   1919864

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mdst-20150930.xml EX-101.INS 275297
7 XBRL SCHEMA FILE mdst-20150930.xsd EX-101.SCH 25284
8 XBRL CALCULATION FILE mdst-20150930_cal.xml EX-101.CAL 31994
9 XBRL DEFINITION FILE mdst-20150930_def.xml EX-101.DEF 54483
10 XBRL LABEL FILE mdst-20150930_lab.xml EX-101.LAB 177037
11 XBRL PRESENTATION FILE mdst-20150930_pre.xml EX-101.PRE 125652
Mailing Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4
Business Address 429 KENT STREET UNIT 112 OTTAWA A6 K2P 2B4 613 241-9969
CTT PHARMACEUTICAL HOLDINGS, INC. (Filer) CIK: 0001035422 (see all company filings)

EIN.: 113763974 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30651 | Film No.: 151249932
SIC: 1040 Gold and Silver Ores